We report the synthesis, in vitro anti-HIV-1 activity and stability study of a mononucleoside phosphotriester derivative of 3′-azido-2′,3′dideoxythymidine (AZT) bearing a new biolabile phosphate-protection, namely S-pivaloyl-2thioisopropyl (tBuSATP). This transient protection was characterized by the presence of a methyl substituent at the Cα-position of the previously described S-pivaloyl-2-thioethyl (tBuSATE) group.
In order to overcome the dependence of 2′,3′-dideoxynucleoside analogues on nucleoside kinase activation, various research groups have focused their attention on the synthesis and study of phosphorylated entities (pronucleotides), which are able to give rise to the intracellular delivery of the corresponding mononucleotide in a non-dependent nucleoside-kinase pathway (Tan et al., 1999; Périgaud et al., 2000; Wagner et al., 2000) . We were particularly interested in the development of mononucleoside phosphotriester derivatives, incorporating S-acyl-2-thioethyl groups (SATE, Figure 1 ) as biolabile phosphate protections . Studies of the behaviour of bis(SATE) phosphotriester derivatives in CEM-SS total cell extracts (Lefebvre et al., 1995) and in intact cells (Martin et al., 2000) have shown that the decomposition mechanism of bis(SATE) pronucleotides ( Figure 1 ) involves first, an esterase-mediated hydrolysis (step 1) giving rise to an unstable phosphotriester, which decomposes spontaneously (step 2). The resulting mononucleoside SATE phosphodiester is then able to lead to the formation of the corresponding mononucleotide after a similar process.
The delivery of the phosphorylated form could be controlled by varying the acyl moiety of the SATE group. Thus, a sterically hindered environment in the vicinity of the thiol ester bond increased the enzymatic stability of the corresponding pronucleotides. With regards to its relative resistance against esterase hydrolysis, the S-pivaloyl-2thioethyl group (tBuSATE, Figure 2 ) has emerged as a promising biolabile phosphate protection for in vivo experiments . We were then interested in studying the effect of structural modifications on tBuSATE group on the antiviral activity of the resulting mononucleoside phosphotriesters. Consequently, we reported that the increase of the thioalkyl chain length (tBuSATB, Figure 2 ) leads to a more stable phosphate protection compared with the tBuSATE group (Egron et al., 1997) . In this last case, the stability of such compounds has been related to the slow intramolecular nucleophilic displacement (step 2, Figure 1 ) giving rise to the corresponding phosphodiester.
We decided to evaluate the influence of another structural modification on the tBuSATE chain, such as the introduction of an alkyl substituent on the Cα-atom. As with the first model, the methyl group was selected, and we report the synthesis, anti-HIV activity and the stability study of the mononucleoside phosphotriester derivative of AZT 2, bearing a new transient phosphate-protecting group, namely S-pivaloyl-2-thioisopropyl (tBuSATP, Figure 2 ). Influence of a Cα-substitution on the S-pivaloyl-2thioethyl chain on the anti-HIV activity and stability of the resulting zidovudine mononucleoside phosphotriester
Introduction

Materials and methods: chemistry
General methods
Unless otherwise stated, 1 H NMR spectra were recorded at 400 MHz and 13 C NMR spectra at 100 MHz with proton decoupling at ambient temperature. Chemical shifts are given in δ-values referenced to the residual solvent peak (CHCl 3 at 7.26 ppm and 77.0 ppm, HDO at 4.61 ppm) relative to TMS. Deuterium exchange, decoupling and COSY experiments were performed in order to confirm proton assignments. Coupling constants, J, are reported in Hertz. 2D 1 H-13 C hetero-nuclear COSY and DEPT spectra were recorded for the attribution of 13 C signals. Unless otherwise stated, 31 P NMR spectra were recorded at ambient temperature at 81 MHz with proton decoupling and chemical shifts are reported relative to external H 3 PO 4 . FAB mass spectra were recorded on a JMS DX 300 spectrometer ( JEOL, Akishima, Tokyo, Japan), in the positiveion or negative-ion mode using thioglycerol/glycerol (1:1, v/v, G-T) as matrix. Only the nominal mass of ions corresponding to the mass of the lightest bromine isotope is given. However, the bromine-isotope peak intensity patterns were ascertained and agreed with the formula of the ions. UV spectra were recorded on an Uvikon 810 spectrometer (Kontron Instruments, San Diego, Calif., USA). Elemental analyses were carried out by the Service de Microanalyses du CNRS, Division de Vernaison, France. Thin layer chromatography (TLC) was carried out using precoated aluminium sheets of silica gel 60 F 254 (Merck Art. N°105554). Visualization of products was accomplished by UV absorbance, followed by charring with 5% ethanolic sulphuric acid, with heating for nucleoside containing compounds. Phosphorus derivatives were detected by spraying with Hanes molybdate reagent (Hanes & Isherwood, 1949) . Column chromatography was carried out using 40-63 µm silica gel (Merck Art. N o 109385). Analytical high performance liquid chromatography (HPLC) studies were carried out on a Waters Assoc. unit (600E multisolvent delivery system, 600E system gradient controller, 717 autosampler injector, 996 photodiode detector and a Millenium data workstation) using a reversephase analytical column (Nucleosil, C 18 , 150×4.6 mm, 5µm, Waters Technologies, Wexford, Ireland) equipped with a pre-filter, a pre-column (Nucleosil, C 18 , 5 µm) and a photodiode array detector (detection at 267 nm).
Phosphorylated derivatives were eluted using a linear gradient of 0-80% acetonitrile in 20 mM triethylammonium acetate buffer (pH 6.9) for 30 min at 1 ml/min flow rate. Moisture sensitive reactions involving phosphoramidite were carried out under argon atmosphere using oven-dried glassware. Solvents were dried and distilled before use and solids were dried over P 2 O 5 under reduced pressure at room temperature. All aqueous solutions were saturated with the specified salt unless otherwise indicated. Organic solutions were dried over Na 2 SO 4 after workup and solvents were removed by evaporation at reduced pressure. AZT was from Brantford Chemicals (Brantford, Canada). Bis(tBuSATE) phosphotriester derivative of AZT 1 (Lefebvre et al., 1995) and tBuSATE phosphodiester derivative of AZT 8 (Shafiee et al., 2001) were synthesized using previously published procedures.
S-(2-Hydroxypropyl) thiopivaloate, 3
To an ice-cooled solution of thiopivaloic acid (112 mg, 1.0mmol) in anhydrous toluene (6.0 ml), 1,8-diazabicyclo(5.4.0)-undec-7-ene (DBU, 0.15 ml, 1.0 mmol) and 1bromo-2-propanol (0.9 ml, 1.0 mmol) were added dropwise. The mixture was stirred at 0°C for 1 h and at room temperature for 1 h. The reaction mixture was filtered, and the precipitate of DBU bromide was washed with toluene. The combined filtrates were washed with water and the aqueous layer was extracted by diethyl ether. The organic layers were combined and dried over anhydrous Na 2 SO 4 , concentrated and coevaporated twice with anhydrous hexane. Compound 3 was stored as a 0.2 M solution in anhydrous hexane and used without further purification. IR (CCl 4 ): ν C=O=1684 Procedures for the synthesis of bis(S-pivaloyl-2thioisopropyl) phosphotriester derivative of AZT, 2 Pathway A. A mixture of 5′-O-phosphoryl-3′-azido-2′,3′dideoxythymidine, acidic form (AZTMP, 35 mg, 0.1mmol), prepared from AZT according to a previously published procedure, (Yoshikawa et al., 1969) and thioester 3 (88 mg, 0.5 mmol) were co-evaporated with anhydrous pyridine and then dissolved in the same solvent (1.5 ml). 2,4,6-tri-isopropylbenzenesulfonyl chloride (TPS-Cl, 151 mg, 0.5 mmol) was added, and the reaction mixture was stirred for 4 h at room temperature. The reaction was stopped by the addition of methanol (5.0 ml) and solvents were evaporated. The residue was dissolved in a mixture of water and chloroform (1:1, v/v), and the aqueous layer was extracted by chloroform. Combined organic layers were dried over anhydrous Na 2 SO 4 and evaporated to dryness. The residue was purified by silica gel column chromatography with a stepwise gradient of ethyl acetate (0-70%) in hexane yielding the title compound 2 as a colourless oil (16 mg, 25%). The aqueous layer was evaporated to dryness and purified by silica gel column chromatography with a gradient of methanol (0-20%) in chloroform, yielding compound 4 after ion-exchange (Dowex 50WX2, Fluka, Buchs, Switzerland, Na + form) and freeze-drying of the resulting aqueous solution (18 mg, 36%). tBuSATB, tBuSATP, 
3′-Azido
the reaction mixture was stirred overnight at room temperature. The reaction was stopped by addition of triethylammonium bicarbonate solution (10 ml, 0.5 M), and the solvents were evaporated. The residue was dissolved in a mixture of water and ethyl acetate (1:1, v/v), and the aqueous layer was extracted by ethyl acetate. Combined organic layers were dried over anhydrous Na 2 SO 4 , and evaporated to dryness. The resulting solid residue underwent chromatography on a silica gel column using a stepwise gradient of methanol (0-3%) in dichloromethane and afforded phosphotriester 5 (395 mg, 67%).The aqueous layer was concentrated, purified on C18 reverse-phase column using a gradient of methanol (0-50%) in water and afforded the corresponding phosphodiester 6 after filtration through an ion-exchange column (Dowex 50WX2, Fluka, Buchs, Switzerland, Na + form) as sodium salt (145 mg, 30%). 3′-Azido-2′,3′-dideoxythymidin-5′-yl bis(S-pivaloyl-2-thioisopropyl) phosphate, 2
To a solution of the phosphotriester 5 (235 mg, 0.4 mmol) in dry acetonitrile (5 ml), potassium thiopivaloic acid salt (312 mg, 2.0 mmol) was added. The mixture was stirred at room temperature in the dark for 4 days. Then the reaction mixture was partitioned between water (20 ml) and chloroform (50 ml). The organic layer was washed with water, dried over anhydrous Na 2 SO 4 and concentrated. The residue was purified by column chromatography on silica gel using a stepwise gradient of ethyl acetate (30-60%) in hexane to afford successively the title compound 2 (140 mg, 53%) and the mixed phosphotriester derivative 7 (61 mg, 25%) as oils. : 40.26, H: 5.31, N: 11.18, found, C: 40.38, H: 5.43 , N: 10.61.
-2′,3′-dideoxythymidin-5′-yl (2-bromo isopropyl) S-pivaloyl-2-thioisopropyl phosphate,
Materials and methods: virology
The origin of the viruses and the techniques used for measuring inhibition of virus multiplication have previously been described (Puech et al., 1993; Lefebvre et al., 1995) . Briefly, in MT-4 cells, determination of the antiviral activity of the test compounds was based on a reduction of HIV-1-IIIB-induced cytopathogenicity. Metabolic activity of the cells was measured by the property of mitochondrial dehydrogenases to reduce 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) into formazan (Pauwels et al., 1988) . For CEM cells, the production of virus HIV-LAI was measured by quantification of reverse S Peyrottes et al. transcriptase activity associated with the virus particle released in the culture supernatant (Puech et al., 1993) . Cells, MT-4 and CEM, were respectively incubated with 50 and 100 TCID 50 of viruses for 30 min. After virus adsorption, unbound particles were eliminated by two washes. Cells were cultured in the presence of different concentrations of test compounds (in 0.1% DMSO) for 5days before virus production determination. The 50% effective concentration (EC 50 ) was derived from the computer-generated median effect plot of the dose-effect data (Chou & Chou, 1985) . In parallel experiments, cytotoxicity of the test compounds was measured after incubating the cells for 5 days with the compounds, using the colorimetric MTT test (Mosmann, 1983) . The 50% cytotoxic concentration (CC 50 ) is the concentration at which OD 540 was reduced by half.
Stability studies
General methods. HPLC analyses were carried out using an improved On-line ISRP cleaning method (Lefebvre et al., 1995) and the same HPLC system, as described above, with the following modifications: the reverse-phase analytical column (Hypersil, Cheshire, UK, BDS C 18 , 100×4.6 mm, 3 µm) was protected by a prefilter as well as a precolumn (Guard-Pak insert, Delta-Pak, Milford, USA, C18, 100 Å) hold in a Guard-Pak holder. The crude sample (80 µl, initial concentration 50 µM) was injected onto the precolumn. Then eluent 20 mM triethylammonium acetate buffer (pH 6.9) was injected for 5 min, the column was connected and the analytes were eluted using a linear gradient of 0-80% acetonitrile for 30 min at 1 ml/min flow rate. The decomposition products were identified after calibration and by coinjection with authentic samples (AZTMP, AZT, phosphodiesters 4 and 8). For each incubation time the calculation of the relative concentration of each species was related to the peak areas. These data were considered as the experimental data. The rate constants of disappearance and the half lives (kinetic data) of the phosphotriester and phosphodiester derivatives were calculated according to pseudo-first order kinetic models and optimized using mono-or poly-exponential regressions. These kinetic models fit the experimental data ( Figure 5 ).
Enzyme assays. Porcine liver esterase (PLE, EC 3.1.1.1., 2800 U/ml) was purchased from Aldrich, Milford, USA. After several attempts, a suitable enzyme concentration for an initial substrate concentration of 50 µM was found to be 0.05 U/ml (in 20 mM phosphate buffer, pH 7.2 at 37°C), and led to measurable half lives of phosphotriesters 1 and 2 in a range of 1 h.
CEM-SS cell extracts were prepared and stability studies were performed according to published procedure (Lefebvre et al., 1995) .
Results
Chemistry
Mononucleoside phosphotriester derivatives can be synthesized following two common strategies using P III phosphoramidite or P V phosphoester intermediates (Gosselin et al., 1996) . First, we decided to explore both of them using the S-(2-hydroxypropyl) thiopivaloate 3 as starting material (Figure 3, pathway A) . The synthesis of this thioester precursor was carried out by reaction of thiopivaloic acid and 1-bromo-2-propanol, commercially available as racemic mixture, in presence of DBU in toluene (Ono et al., 1978) . The crude material has to be used directly for further reaction, due to an easy intramolecular acyl transfer from sulphur to oxygen observed when we tried to purify compound 3 by silica gel column chromatography. Indeed, this migration can occur spontaneously in hydroxythiol esters (Martin & Hedrick, 1962; Crans & Whitesides, 1985; Ward, 1988) , particularly in presence of silica (Sonnet & Mootre, 1989) .
The synthesis of the desired phosphotriester 2 has been envisaged firstly via a procedure established for bis(SATE) pronucleotides (Lefebvre et al., 1995) and involving the use of phosphoramidite reagents. All the attempts to prepare a phosphoramidite derivative bearing the two tBuSATP groups (Figure 3, pathway A) failed and only the corresponding H-phosphoramidate was isolated. By contrast, phosphotriester 2 could be obtained as a diastereoisomeric mixture by an adaptation of a general procedure (Lohrmann and Khorana, 1966) , involving the esterification of AZT 5′-monophosphate (AZTMP) with compound 3 in presence of TPS-Cl in pyridine (Figure 3) . However, the yield of the coupling reaction using pathway A (25%) was significantly lower than the one described for a large scale synthesis of the bis(tBuSATE) phosphotriester derivative 1 (70%) using S-(2-hydroxyethyl) thiopivaloate as precursor (Lannuzel et al., 1999) . This difference could be attributed to the instability of S-(2-hydroxypropyl) thiopivaloate 3 in the reaction media (Ward, 1988) , and also to the weaker reactivity of the secondary alcohol compared with the primary one. This diminished reactivity was illustrated by the isolation of the corresponding phosphodiester 4 in a significant ratio (36%).
Consequently, we decided to explore a new synthetic strategy using stable and/or commercially available precursors (Figure 3, pathway B) . Thus, AZTMP could be esterified by 1-bromo-2-propanol in presence of TPS-Cl, giving rise to the formation a bis(2-bromoisopropyl) phosphotriester derivative of AZT 5 as intermediate, with satisfactory yield (67%). Conversion of the bromoalkyl counterpart to S-pivaloylthioalkyl chain was carried out in one step, using the corresponding thiopivaloic acid potassium salt (Albright et al., 1993 , Deslongchamps et al., 1981 . This new pathway allowed us to isolate the desired phosphotriester 2 in a 35% overall yield (pathway B) instead of 25% (pathway A) using stable intermediates. Structures of all new compounds were confirmed according to analytical and spectroscopic data.
Antiviral evaluation
The new phosphorylated compounds 2 and 4 were evaluat-ed, by comparing them with parent nucleoside (AZT) and with the corresponding tBuSATE pronucleotide 1, for their inhibitory effects on the HIV-1 replication in T 4human lymphoblastoid cells, such as CEM-SS and MT-4 (Table 1 ). In these cell lines, all compounds significantly inhibited the multiplication of HIV-1, with EC 50 values similar to those observed for AZT. More striking differences were found in the antiviral activities of the tested (Table 1) . This cell line is highly deficient in cytosolic TK, and should be considered as an ideal in vitro system to investigate the antiviral potency of thymine containing nucleotide analogues that may release the corresponding mononucleotide into the cells . The differences observed in the anti-HIV activities of the mononucleotide prodrugs of AZT in the TK + and TKcell lines could be tentatively explained by the particular metabolism of this nucleoside analogue and by the kinetic parameters involved in the decomposition of all derivatives. Indeed, the second phosphorylation step of AZT, catalysed by a thymidilate kinase, constitutes the rate-limiting step in the anabolism of AZT to its 5′triphosphate. Furthermore, the intracellular accumulation of AZTMP causes inhibition of the thymidilate kinase resulting in a blockage of further phosphorylation to AZT 5′-diphosphate. Moreover, AZTMP could be either excreted from cells or/and dephosphorylated into AZT by phosphatases.
In TK + cells, these excretion and catabolism phenomenon would not have hampered the observation of the antiviral activity for an AZTMP prodrug because the nucleoside analogue is still available, and could enter cells by passive diffusion, and be metabolized to AZTMP by cytosolic TK. In TKcells, the amount of AZT generated from the parent prodrug cannot contribute to the anti-HIV effect. Consequently, a pronucleotide derivative of AZT cannot exhibit an in vitro anti-HIV activity greater than AZT, in cell lines where the activity of cytosolic thymidine kinase is expressed, as previously demonstrated in various AZTMP prodrug series (McGuigan et al., 1993; Lefebvre et al., 1995; Wagner et al., 1995; Meier et al., 1998) . Thus, in CEM/TKcells, the phosphotriester derivative 2 exhibited antiviral activity at micromolar concentration, whereas AZT proved to be completely inactive against HIV-1 replication, showing its ability to act as a pronucleotide. The corresponding phosphodiester 4 has a very weak anti-HIV effect with an EC 50 value at 70 µM. This loss of activity could be explained by the low capacity of this anionic entity to enter cells and by its decomposition into the parent nucleoside in the culture medium resulting from phosphodiesterase activity present in fetal calf serum.
Stability studies
Stability studies have been performed in order to correlate the antiviral evaluation data with the expected decomposition mechanism and to support our hypothesis on the behaviour of such constructs. According to a published procedure used for the stability study of the reference pronucleotide 1 (Lefebvre et al., 1995 (Lefebvre et al., , 1997 , the decomposition pathways and kinetic data of compounds 2 and 4 ( Table 2) were carried out in the presence of a purified enzyme like PLE (EC 3.1.1.1.), as well as total CEM-SS extracts (TCE). The metabolites formed during the incubation of both phosphotriester 2 and phosphodiester 4 were identified using coinjection with authentic samples or by HPLC/MS coupling.
In presence of PLE, the bis(tBuSATP) phosphotriester 2 proved to be substrate for esterase activity. This new pronucleotide appeared to be twice as stable as the bis(tBuSATE) analogue 1 in the conditions used (0.05 unit of enzyme per ml), and a similar difference was observed in TCE. As previously demonstrated with bis(SATE) pronucleotide series (Lefebvre et al., 1995) , the sulphuridryl phosphotriester intermediate (Figure 4) could not be detected due to its chemical instability. Consequently, the observed half lives of phosphotriesters 1 and 2 result from a first two-step process that could not be dissociated at this stage. (Lefebvre et al., 1995) .
Influence of Cα-substitution in tBuSATE pronucleotides Antiviral Chemistry & Chemotherapy 12:4 7 By contrast, the presence of a negative charge in the resulting phosphodiesters 4 and 8 decreased the esterase affinity as well as the rate of the intramolecular nucleophillic substitution (S N i). Thus, in TCE we were able to visualize the formation of the sulphuridryl intermediates 9 and 10 from the corresponding phosphodiesters 8 and 4, respectively (Figures 4 and 5) . In the two-step process, the enzymatic hydrolysis, resulting in the removal of the acyl group, was two times more rapid for the tBuSATP phosphodiester 4 than for its tBuSATE analogue 8 (Table 2) . This finding could be related to the slight increase of lipophilicity induced by the presence of the methyl group, as shown by the calculated log P values of the two compounds (Table 3) . Indeed, the lipophilicity is a key parameter for the substrate affinity of carboxylesterases, the most probable candidates for the decomposition of the studied phosphodiesters in TCE (Heymann, 1980; Satoh, 1987) The resulting 2-mercaptoisopropyl phosphodiester 10 appeared to be much more stable than its sulphuridryl analogue 9. The chemical stability of these two intermediates is associated with the rate of the intramolecular nucleophilic displacement. The pKa of the thiol functions in various mercaptoethanol derivatives (about 9.5) being similar (Whitesides et al., 1977 (Whitesides et al., , 1983 , the S N i was slowed down by the presence of the methyl group. Illustrated with the hydrolysis of dialkyl phosphotriesters in neutral conditions, the attack of a 'soft' nucleophile on the Cα-atom is dependent of both steric and electronic effects (Cox & Ramsay, 1964) . Thus, the introduction on the SATE chain, at the Cα-position, of a bulky and electron-donating substituent decreased the rate of the chemical decomposition step leading to the mononucleotide formation ( Figure 4 ) by steric hindrance and by altering the electron density of the electrophilic centre.
Discussion
Two ways of synthesis have been used to obtain the bis(tBuSATP) phosphotriester derivative of AZT, 2. The second pathway (Figure 3, pathway B) , involved the formation of the thioester linkage by substitution of a leaving group on the bis(2-bromopropyl) phosphotriester derivative of AZT, 5, with a thioacid salt, and allowed us to isolate the targeted compound in improved yield using stable intermediates and commercially available precursors.
The data presented here strongly support the hypothesis that such a phosphotriester derivative of AZT, bearing the new tBuSATP phosphate protecting group, was able to give rise to the intracellular delivery of the corresponding S Peyrottes et al. 5′-mononucleotide (AZTMP). Differences observed between the anti-HIV-1 activities of phosphotriester 2 and the corresponding tBuSATE pronucleotide 1 in CEM/TKcells can be related to their kinetics of decomposition inside the cells. Indeed, comparison of EC 50 values in the corresponding cell line (Table 1 ) and estimated half lives of AZTMP formation (Table 2) indicated that the weaker anti-HIV activity of the bis(tBuSATP) phosphotriester 2 is probably correlated to the higher stability in TCE of the 2-mercaptoisopropyl phosphodiester intermediate 10 ( Figure 5 ), leading to a slower rate of AZTMP release. These results, observed in other pronucleotide series (Peyrottes et al., 2001) , illustrate the time-dependent relation required between the kinetic release of the mononucleotide from the prodrug and the expression of the targeted process (that is. reverse transcription) in order to observe biological effect in vitro (Balzarini et al., 1999; Liu et al., 2000; Périgaud et al., 2000) . Furthermore, we shown that the decomposition mechanism for this new phosphorylated prodrug is similar to those previously published for bis(SATE) pronucleotides (Lefebvre et al., 1995) . Related to steric and electronic effects, the introduction of a methyl group at the Cα-position of the tBuSATE chain gives rise to a decrease of the kinetic release of the mononucleotide. The large number of substituents, which could be introduced on this position, as well as chemical modifications on the acyl moiety, opens the way to the search for antiviral mononucleotide prodrugs. An adequate balance between aqueous solubility, lipophilicity, and enzymatic stability is needed in order to envisage further in vivo studies. 
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